SCHWARTZ NORMAN D 4

Accession 0001062993-24-016174

CIK 0000012208other

Filed

Sep 3, 8:00 PM ET

Accepted

Sep 4, 8:35 PM ET

Size

31.2 KB

Accession

0001062993-24-016174

Form 4

Period: 2024-09-01

DirectorCEO10% Owner

Transactions

Exercise/Conversion
Bio-Rad A Common Stock
2024-09-01+3,005→ 435,925 total
Tax Payment
Bio-Rad A Common Stock
2024-09-01$337.32/sh−1,607$542,073→ 434,318 total
Exercise/Conversion
Bio-Rad A Common Stock
2024-09-01+2,081→ 436,399 total
Tax Payment
Bio-Rad A Common Stock
2024-09-01$337.32/sh−801$270,193→ 435,598 total
Exercise/Conversion
Bio-Rad A Common Stock
2024-09-01+1,266→ 436,864 total
Tax Payment
Bio-Rad A Common Stock
2024-09-02$337.32/sh−965$325,514→ 437,159 total
Exercise/Conversion
Restricted Stock Units
2024-09-01−3,005→ 9,015 total
Exercise: $0.00→ Bio-Rad A Common Stock (3,005 underlying)
Exercise/Conversion
Restricted Stock Units
2024-09-01−2,081→ 4,164 total
Exercise: $0.00→ Bio-Rad A Common Stock (2,081 underlying)
Exercise/Conversion
Restricted Stock Units
2024-09-02−1,805→ 0 total
Exercise: $0.00→ Bio-Rad A Common Stock (1,805 underlying)
Tax Payment
Bio-Rad A Common Stock
2024-09-01$337.32/sh−545$183,839→ 436,319 total
Exercise/Conversion
Bio-Rad A Common Stock
2024-09-02+1,805→ 438,124 total
Exercise/Conversion
Bio-Rad A Common Stock
2024-09-03+2,320→ 439,479 total
Tax Payment
Bio-Rad A Common Stock
2024-09-03$334.31/sh−1,241$414,879→ 438,238 total
Exercise/Conversion
Restricted Stock Units
2024-09-01−1,266→ 1,266 total
Exercise: $0.00→ Bio-Rad A Common Stock (1,266 underlying)
Exercise/Conversion
Restricted Stock Units
2024-09-03−2,320→ 0 total
Exercise: $0.00→ Bio-Rad A Common Stock (2,320 underlying)

Holdings

Footnotes (9)

[F1]Shares of Class A common stock acquired on the vesting of restricted stock units.
[F2]The reporting person disclaims beneficial ownership of these shares.
[F3]The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
[F4]Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
[F5]On September 1, 2023, the reporting person was granted 12,020 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
[F6]On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
[F7]On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
[F8]On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
[F9]On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.

Documents

1 file

BIO-RAD LABORATORIES, INC.

CIK 0000012208

Entity typeother